Galderma Group AG (GALDY)
38.91
+0.15
(+0.39%)
USD |
OTCM |
Oct 05, 16:00
Galderma Group 1 Year Total Returns (Daily) : 9.04% for Oct. 5, 2026
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| October 05, 2026 | 9.04% |
| October 02, 2026 | 12.62% |
| October 01, 2026 | 14.31% |
| September 30, 2026 | 13.26% |
| September 29, 2026 | 16.75% |
| September 28, 2026 | 15.28% |
| September 25, 2026 | 16.52% |
| September 24, 2026 | 11.78% |
| September 23, 2026 | 10.48% |
| September 22, 2026 | 11.50% |
| September 21, 2026 | 8.38% |
| September 18, 2026 | 5.85% |
| September 17, 2026 | 4.07% |
| September 16, 2026 | 1.03% |
| September 15, 2026 | 1.21% |
| September 14, 2026 | 3.88% |
| September 11, 2026 | 3.14% |
| September 10, 2026 | 2.61% |
| September 09, 2026 | 5.09% |
| September 08, 2026 | 9.78% |
| September 04, 2026 | 10.77% |
| September 03, 2026 | 17.11% |
| September 02, 2026 | 19.17% |
| September 01, 2026 | 16.79% |
| August 31, 2026 | 18.28% |
| Date | Value |
|---|---|
| August 28, 2026 | 21.44% |
| August 27, 2026 | 21.87% |
| August 26, 2026 | 23.85% |
| August 25, 2026 | 25.98% |
| August 24, 2026 | 26.02% |
| August 21, 2026 | 27.19% |
| August 20, 2026 | 27.36% |
| August 19, 2026 | 29.29% |
| August 18, 2026 | 25.44% |
| August 17, 2026 | 27.25% |
| August 14, 2026 | 30.50% |
| August 13, 2026 | 35.34% |
| August 12, 2026 | 32.34% |
| August 11, 2026 | 33.05% |
| August 10, 2026 | 34.60% |
| August 07, 2026 | 39.90% |
| August 06, 2026 | 38.89% |
| August 05, 2026 | 38.60% |
| August 04, 2026 | 36.02% |
| August 03, 2026 | 32.83% |
| July 31, 2026 | 39.83% |
| July 30, 2026 | 43.48% |
| July 29, 2026 | 35.91% |
| July 28, 2026 | 37.08% |
| July 27, 2026 | 25.26% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Sandoz Group AG | 46.47% |
| Novartis AG | 9.69% |
| Roche Holding AG | 19.50% |
| Addex Therapeutics Ltd. | -66.30% |
| Oculis Holding AG | -51.28% |